U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Meeting: Progress Toward Implementing the Product Identification Requirements of the Drug Supply Chain Security Act
  1. Drugs

Public Meeting: Progress Toward Implementing the Product Identification Requirements of the Drug Supply Chain Security Act

Public Meeting: Progress Toward Implementing the Product Identification Requirements of the Drug Supply Chain Security Act

The FDA held a public meeting on October 14, 2016, entitled “Progress Toward Implementing the Product Identification Requirements of the Drug Supply Chain Security Act.”

This public meeting provided members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to share information with FDA about the efforts under way to implement the DSCSA’s product identification requirements.

Federal Register Notice

Contact Information
Daniel Bellingham, Office of Compliance, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-3130, FAX: 301-847-8722, email: CDERODSIRpublicmeetings@fda.hhs.gov

Agenda and Meeting Information

Comments
To access electronic comments regarding the topics of the public meeting, please visit http://www.regulations.gov and search the Docket No. FDA-2016-N-2673.

Other Resources